Rapid and sustained pain improvement in rheumatoid arthritis patients treated with baricitinib compared to adalimumab or placebo

Gelijkaardige items

• Baricitinib versus placebo or adalimumab in rheumatoid arthritis
  door: Taylor, P, et al.
  Gepubliceerd in: (2017)
• Improved patient-reported outcomes in patients with rheumatoid arthritis who failed adalimumab or placebo treatment and were rescued with baricitinib
  door: Fautrel, B, et al.
  Gepubliceerd in: (2017)
• Achieving pain control in rheumatoid arthritis with baricitinib or ddalimumab plus methotrexate: Results from the RA-BEAM Trial
  door: Taylor, P, et al.
  Gepubliceerd in: (2019)
• Effect of baricitinib and adalimumab in reducing pain and improving function in patients with rheumatoid arthritis in low disease activity: exploratory analyses from RA-BEAM
  door: Fautrel, B, et al.
  Gepubliceerd in: (2019)
• Assessment of pain improvement in rheumatoid arthritis patients treated with baricitinib, who were inadequate responders to methotrexate and tumor necrosis factor inhibitors
  door: Taylor, P, et al.
  Gepubliceerd in: (2019)